SECsense Logo

Aptevo Therapeutics Inc. 8-K Report: Key Insights for Investors

$APVO
Form 8-K
Filed on: 2025-02-14
Source
Aptevo Therapeutics Inc. 8-K Report: Key Insights for Investors

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Aptevo Therapeutics Inc.
  • CIK Number: 0001671584
  • SEC File Number: 001-37746
  • EIN: 81-1567056
  • Address: 2401 4th Avenue Suite 1050, Seattle, WA 98121
  • Phone Number: (206) 838-0500
  • Stock Symbol: APVO (traded on NASDAQ)
  • Common Stock Par Value: $0.001
  1. Filing Information:
  • Filing Type: 8-K (Current Report)
  • Filing Date: February 14, 2025
  1. Report Context:
  • The document is formatted in XBRL (eXtensible Business Reporting Language), indicating it is structured for digital consumption and analysis.
  1. Period of Reporting:
  • Start Date: February 14, 2025
  • End Date: February 14, 2025
  • The period is listed as a single day, which may suggest a specific event or occurrence being reported on that date.
  1. Additional Notes:
  • The filing indicates there is no applicable information under certain categories (indicated by "Not Applicable" and "false" entries).

This section mainly provides the basic identification and context for Aptevo Therapeutics Inc.'s filing, which is crucial for investors or analysts looking to track the company’s regulatory disclosures and stock performance.